- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05588570
Coaching Children With Anxiety and Autism Through Telehealth (CAT)
February 29, 2024 updated by: Laura Arnstein Carpenter, Medical University of South Carolina
This study will examine a telehealth parenting intervention to reduce anxiety in 20 families of children between 4 and 8 years old with autism and anxiety.
Caregivers and children complete 12 telehealth treatment sessions.
Caregivers and children will complete pre tests, post tests, and 3 month followup assessments that include observations, heart rate monitoring, and caregiver ratings.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will examine the feasibility and initial efficacy of a telehealth adaptation of a parenting intervention to reduce anxiety (Coaching Approach behavior Leading by Modeling; CALM) amongst 20 families of children between 4 and 8 years old with autism and anxiety.
Our time limited telehealth-delivered adaptation of CALM is called CAT (Coaching Children with Anxiety and Autism through Telehealth).
The study will utilize an open trial design with pre, post, and 3-month follow-up assessments including observational measures, physiological measures, and caregiver ratings.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 5 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Child participants must:
- Be between 4:0-8:11 years old
- Have clinically significant caregiver-report symptoms of anxiety on the Parent-Rated Anxiety Scale for ASD (PRAS-ASD)
- Have a primary anxiety concern on the Anxiety Disorders Interview Schedule for Autism Spectrum and Developmental Disorders: Parent Version (ADIS/ASA)
- Have an ASD diagnosis made by a qualified diagnostician
- Have a cognitive level of 48 months on the Wechsler Preschool & Primary Scale of Intelligence-Fourth Edition (WPPSI-IV; ages 2:6-7:7) or the Wechsler Intelligence Scale for Children-Fifth Edition (WISC-V; ages 6:0-16:11)
Caregiver participants must:
- Have access to a computer, tablet, or phone with a camera and Wi-Fi access
Exclusion Criteria:
- Primary concern other than anxiety as measures on the ADIS/ASA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CAT
Participants will receive behavioral treatment for anxiety.
|
Treatment includes 12 sessions: 2 caregiver teach sessions, 4 caregiver coach sessions in the child-directed interaction (CDI) phase, and 6 caregiver coach sessions in the DADS (Describe situation, Approach situation, give Direct command for child to join situation, provide Selective attention based on child's performance) phase.
Throughout the 12 sessions, caregivers are coached through exposures in which the child is given the opportunity to slowly encounter anxiety-provoking factors.
In the first session, caregivers are provided psychoeducation on anxiety and parenting practices and taught PRIDE (praise, reflect, imitate, describe, enjoy) skills, which are aimed at increasing approach behaviors and decreasing avoidant behaviors.
In the CDI phase, caregivers are coached live via Bluetooth headset through the PRIDE and active ignoring skills.
In the last 5 sessions, caregivers are coached through the DADS protocol while working up the Fear Hierarchy with the child.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Child Anxiety Symptoms as assessed by PRAS-ASD
Time Frame: Pre to Post (~14 weeks)
|
The Parent Rated Anxiety Scale for ASD (PRAS-ASD) is a 25-item measure.
Parents score severity of various anxiety symptoms on a scale of 0-3.
The PRAS-ASD yields a total raw score for severity of anxiety and a normed T-score with higher scores indicating higher anxiety severity.
The cut-off for clinical significance is a raw score of 44.
|
Pre to Post (~14 weeks)
|
|
Change in Child Anxiety Symptoms as assessed by PRAS-ASD
Time Frame: Pre to Follow-up (~26 weeks)
|
The Parent Rated Anxiety Scale for ASD (PRAS-ASD) is a 25-item measure.
Parents score severity of various anxiety symptoms on a scale of 0-3.
The PRAS-ASD yields a total raw score for severity of anxiety and a normed T-score with higher scores indicating higher anxiety severity.
The cut-off for clinical significance is a raw score of 44.
|
Pre to Follow-up (~26 weeks)
|
|
Change in Parent Accommodation as assessed by FAS-A
Time Frame: Pre to Post (~14 weeks)
|
The Family Accommodation Scale-Anxiety (FAS-A) is a 9 item measure.
Parents score the amount that they accommodate their child's anxiety on a 0-4 frequency scale.
The FAS-A yields a total raw score for accommodations and a normed T-score with higher scores indicating more accommodations.
|
Pre to Post (~14 weeks)
|
|
Change in Parent Accommodation as assessed by FAS-A
Time Frame: Pre to Follow-up (~26 weeks)
|
The Family Accommodation Scale-Anxiety (FAS-A) is a 9 item measure.
Parents score the amount that they accommodate their child's anxiety on a 0-4 frequency scale.
The FAS-A yields a total raw score for accommodations and a normed T-score with higher scores indicating more accommodations.
|
Pre to Follow-up (~26 weeks)
|
|
Child Heart Rate
Time Frame: Pre to Post (~14 weeks)
|
Change in heart rate during structured play interaction from pre to post
|
Pre to Post (~14 weeks)
|
|
Parent Heart Rate
Time Frame: Pre to Post (~14 weeks)
|
Change in heart rate during structured play interaction from pre to post
|
Pre to Post (~14 weeks)
|
|
Child Respiratory Sinus Arrhythmia as assessed by Actiheart software
Time Frame: Pre to Post (~14 weeks)
|
Change in respiratory sinus arrhythmia during structured play interaction from pre to post while participant is wearing Actiheart electrodes.
After heart activity is collected, Actiheart software is used to analyze Respiratory Sinus Arrhythmia (RSA)
|
Pre to Post (~14 weeks)
|
|
Parent Respiratory Sinus Arrhythmia as assessed by Actiheart software
Time Frame: Pre to Post (~14 weeks)
|
Change in respiratory sinus arrhythmia during structured play interaction from pre to post while participant is wearing Actiheart electrodes.
After heart activity is collected, Actiheart software is used to analyze Respiratory Sinus Arrhythmia (RSA)
|
Pre to Post (~14 weeks)
|
|
Parent Anxiety Symptoms as assessed by GAD-7
Time Frame: Pre to Post (~14 weeks)
|
The Generalized Anxiety Disorder (GAD-7) is a 7-item screening tool to assess for adult anxiety.
Parents score their anxiety symptoms on a 0-3 frequency scale.
The GAD-7 yields a total raw score for level of anxiety and a normed T-score with higher scores indicating higher levels of anxiety.
The cut-off for clinical significance is a raw score of 8.
|
Pre to Post (~14 weeks)
|
|
Parent Anxiety Symptoms as assessed by GAD-7
Time Frame: Pre to Follow-up (~26 weeks)
|
The Generalized Anxiety Disorder (GAD-7) is a 7-item screening tool to assess for adult anxiety.
Parents score their anxiety symptoms on a 0-3 frequency scale.
The GAD-7 yields a total raw score for level of anxiety and a normed T-score with higher scores indicating higher levels of anxiety.
The cut-off for clinical significance is a raw score of 8.
|
Pre to Follow-up (~26 weeks)
|
|
Change in Parenting Stress as assessed by Parenting Stress Index-Short Form (PSI-SF)
Time Frame: Pre to Post (~14 weeks)
|
Parents will complete the PSI-SF, a 36-item measure yielding scores for a Total Stress scale.
The PSI-SF is a widely used measure in ASD samples and has been used as an outcome measure in PCIT ASD studies.
The PSI-SF yields a total raw score for stress level and a percentile score which describes parent stress relative to all parents assessed during the development and testing of the PSI.
Scores above 80 are considered high stress scores.
|
Pre to Post (~14 weeks)
|
|
Change in Parenting Stress as assessed by Parenting Stress Index-Short Form (PSI-SF)
Time Frame: Pre to Follow (~26 weeks)
|
Parents will complete the PSI-SF, a 36-item measure yielding scores for a Total Stress scale.
The PSI-SF is a widely used measure in ASD samples and has been used as an outcome measure in PCIT ASD studies.
The PSI-SF yields a total raw score for stress level and a percentile score which describes parent stress relative to all parents assessed during the development and testing of the PSI.
Scores above 80 are considered high stress scores.
|
Pre to Follow (~26 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Satisfaction with treatment as assessed by Therapy Attitude Inventory (TAI)
Time Frame: Pre to Post (~14 weeks)
|
To assess treatment satisfaction, parents will complete the TAI, which is widely used in PCIT studies.
Several questions will be added to the TAI to address parental satisfaction and openness regarding the telehealth delivery format for families in the Tele-PCIT condition.
The TAI uses a Likert-type satisfaction scale and scores will be reported via descriptive statistics with 95% CIs within categories.
|
Pre to Post (~14 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 23, 2022
Primary Completion (Actual)
January 31, 2024
Study Completion (Actual)
January 31, 2024
Study Registration Dates
First Submitted
June 13, 2022
First Submitted That Met QC Criteria
October 18, 2022
First Posted (Actual)
October 20, 2022
Study Record Updates
Last Update Posted (Actual)
March 4, 2024
Last Update Submitted That Met QC Criteria
February 29, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00121415
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on CAT
-
Aier School of Ophthalmology, Central South UniversityUnknown
-
National Institute of Allergy and Infectious Diseases...Circassia LimitedCompletedCat Allergy | Cat HypersensitivityCanada
-
MedImmune LLCAstraZeneca; MedImmune LtdCompleted
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)TerminatedAsthma AtopicUnited States
-
Massachusetts General HospitalCompletedHand SurgeryUnited States
-
Swiss Tropical & Public Health InstituteCompletedSatisfaction | Station AtmosphereSwitzerland
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
Circassia LimitedCetero Research, San Antonio; Adiga Life Sciences, Inc.Completed
-
University Hospital, GrenobleActive, not recruitingAnorexia NervosaFrance
-
Boston Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...WithdrawnDiabetes Mellitus, Type 2United States